1-6 of 6
Anticancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Aerobic exercise alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis

Available to Purchase
Subject Area:
Further Areas , Oncology , Pharmacology
Haiyun Liu, Hongmei Li, Nihong Zhou, Yimin Zhang, Lijing Gong, Enming Zhang
Journal: Chemotherapy
Chemotherapy (2025)
https://doi.org/10.1159/000546096
Published Online: 10 May 2025
View articletitled, Aerobic exercise alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis
Open the PDF for Aerobic exercise alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis in another window
Journal Articles

Cryoablation Combined with Programmed Cell Death Protein 1 Inhibitor Pembrolizumab for Advanced Non-Small Cell Lung Cancer

Available to Purchase
Subject Area:
Further Areas , Oncology , Pharmacology
Li Wang, Kai Yang, Xinxin Xie, Hailiang Wei, Pengli Wang, Shaohui Wang
Journal: Chemotherapy
Chemotherapy (2025)
https://doi.org/10.1159/000545185
Published Online: 13 March 2025
View articletitled, Cryoablation Combined with Programmed Cell Death Protein 1 Inhibitor Pembrolizumab for Advanced Non-Small Cell Lung Cancer
Open the PDF for Cryoablation Combined with Programmed Cell Death Protein 1 Inhibitor Pembrolizumab for Advanced Non-Small Cell Lung Cancer in another window
Journal Articles

The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-Small Cell Lung Cancer

Available to Purchase
Subject Area:
Further Areas , Oncology , Pharmacology
Daiki Murata, Koichi Azuma, Yuuya Nishii, Kenta Murotani, Goushi Matama, Akihiko Kawahara, Takaaki Tokito, Tetsuro Sasada, Tomoaki Hoshino
Journal: Chemotherapy
Chemotherapy (2025)
https://doi.org/10.1159/000543425
Published Online: 22 January 2025
View articletitled, The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-Small Cell Lung Cancer
Open the PDF for The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-Small Cell Lung Cancer in another window
Journal Articles

Safety and Efficacy of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Pegfilgrastim in Japanese Patients with Advanced or Metastatic Urothelial Carcinoma

Open Access
Subject Area:
Further Areas , Oncology , Pharmacology
Takahiro Harano, Masaomi Ikeda, Shuhei Hirano, Soichiro Shimura, Masayoshi Toyoda, Satoshi Okuda, Dai Koguchi, Hideyasu Tsumura, Daisuke Ishii, Kazumasa Matsumoto
Journal: Chemotherapy
Chemotherapy 85–91.
https://doi.org/10.1159/000543333
Published Online: 30 December 2024
View articletitled, Safety and Efficacy of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Pegfilgrastim in Japanese Patients with Advanced or Metastatic Urothelial Carcinoma
Open the PDF for Safety and Efficacy of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Pegfilgrastim in Japanese Patients with Advanced or Metastatic Urothelial Carcinoma in another window
Journal Articles

Therapeutic Drug Monitoring, Population Pharmacokinetics Models, and External Validation of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia

Available to Purchase
Subject Area:
Further Areas , Oncology , Pharmacology
Natalia Maximova, Pasquale Fabio Calabrò, Alice Cangialosi, Antonello Di Paolo
Journal: Chemotherapy
Chemotherapy (2024)
https://doi.org/10.1159/000543181
Published Online: 18 December 2024
View articletitled, Therapeutic Drug Monitoring, Population Pharmacokinetics Models, and External Validation of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia
Open the PDF for Therapeutic Drug Monitoring, Population Pharmacokinetics Models, and External Validation of High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia in another window
Journal Articles

Downregulation of Rad51 Expression and Activity Potentiates the Cytotoxic Effect of Osimertinib in Human Non-Small Cell Lung Cancer Cells

Available to Purchase
Subject Area:
Further Areas , Oncology , Pharmacology
Jen-Chung Ko, Jyh-Cheng Chen, Ching-Hsiu Huang, Pei-Jung Chen, Qiao-Zhen Chang, Bo-Cheng Mu, Jun-Jie Chen, Tzu-Yuan Tai, Kasumi Suzuki, Yi-Xuan Wang, Yun-Wei Lin
Journal: Chemotherapy
Chemotherapy (2025) 70 (1): 12–25.
https://doi.org/10.1159/000540867
Published Online: 10 August 2024
View articletitled, Downregulation of Rad51 Expression and Activity Potentiates the Cytotoxic Effect of Osimertinib in Human Non-Small Cell Lung Cancer Cells
Open the PDF for Downregulation of Rad51 Expression and Activity Potentiates the Cytotoxic Effect of Osimertinib in Human Non-Small Cell Lung Cancer Cells in another window